Medical Device News Magazine

Shawn Guertin Will Join Davida’s BOD Effective September 15

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 8, 2020

Shawn Guertin will join the Davida board of directors, effective Sept. 15.

Shaw Guertin joins the Board with nearly 35 years of health care experience.  Most recently, Mr. Guertin spent eight years at Aetna, Inc., where he served as executive vice president, chief financial officer and chief enterprise risk officer during a period of significant growth driven by acquisitions and expansion into government programs, leading to Aetna’s eventual merger into CVS Health. At Aetna, Mr. Guertin was a key member of the executive leadership team driving the overall strategic direction of the enterprise and leading the development of the financial strategy to help grow the company into a multifaceted, dynamic health care organization.

“We are thrilled to have Shawn’s deep health care and managed care experience as part of our Board to help us continue to develop and execute on our strategy to transform kidney care,” said Javier Rodriguez, CEO of DaVita Inc. “He adds to our deep bench of financial and operational strength.”

“The expertise Shawn has cultivated throughout his career and, most recently at Aetna and CVS Health, will help DaVita continue to grow and lead within the larger health care community,” said Pam Arway, independent chair of the DaVita Inc. Board of Directors.

Mr. Guertin started his career as an actuary for The Travelers, where he held a number of roles over 11 years, eventually becoming part of the leadership of its group health business that was acquired by UnitedHealthcare.  After working for UnitedHealthcare, Guertin joined Coventry Health Care, where he spent 12 years, including serving as chief actuary and chief financial officer.

“DaVita’s commitment to its patients, teammates, partners and to true transformation in health care was part of the inspiration to join this team,” said Mr. Guertin. “I am excited to share my perspectives on managed care, capital planning and strategic direction as DaVita executes on its innovative strategy.”

Mr. Guertin will serve on DaVita’s audit committee. He also holds a position on the TriNet Board of Directors.

With the addition of Mr. Guertin, the DaVita Board is comprised of ten highly qualified directors, with 40% racial/ethnic and 40% gender diversity.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”